Modulated release of 5-fluorouracil from pH-sensitive and colon targeted pellets: An industrially feasible approach

Pellets, reliant on pH-sensitivity and time-dependency for drug delivery, provide one of the most versatile opportunities for targeting colon. 5-Fluorouracil (5-FU) loaded pellets were prepared by extrusion-spheronization using Avicel® PH101 as a spheronization aid and hydroxypropylmethylcellulose K4M (HPMC K4M) solution as a binder. A 32 full factorial design was employed to optimize spheronization speed and time. Obtained pellets were evaluated for flow properties, pellet size, roundness and aspect ratio. Optimized batch was coated in a bottom-spray fluidized bed processor (FBP) with an inner coat of sustained release polymer Eudragit NE30D and an outer coat of pH-sensitive polymer Eudragit FS30D. The coating levels were statistically optimized and in vitro drug release was monitored by changing pH media method. Optimized system with 15% inner and outer coating levels revealed t50% (time required for 50% drug release) to be about 9 h while almost complete drug was released in 24 h (98.71 ± 1.33%) with highest dissolution efficiency (DE24h) of 58.71%. The optimization model was validated; the predicted and experimental/actual values for validation batch (M1) were in close tolerance and the standard error (SE) was also small. Drug release was also studied at pH 7.4. Scanning electron microscopy (SEM) demonstrated average coating thickness to be 32.50 ± 3.0 µm. Hence, the present study provides constructive results for colon targeting of 5-FU pellets with industrially feasible processes.

[1]  A. Basit Advances in Colonic Drug Delivery , 2012, Drugs.

[2]  Zhirong Zhang,et al.  Development of multiple-unit colon-targeted drug delivery system by using alginate: in vitro and in vivo evaluation , 2011, Drug development and industrial pharmacy.

[3]  J. Muselík,et al.  Coated hard capsules as the pH-dependent drug transport systems to ileo-colonic compartment , 2011, Drug development and industrial pharmacy.

[4]  M. D. Blanco,et al.  In Vitro and In Vivo Evaluation of a Folate-Targeted Copolymeric Submicrohydrogel Based on N-Isopropylacrylamide as 5-Fluorouracil Delivery System , 2011 .

[5]  Xing Tang,et al.  Preparation and evaluation of nicotinic acid sustained-release pellets combined with immediate release simvastatin. , 2010, International journal of pharmaceutics.

[6]  S. Gattani,et al.  Development of colon targeted multiparticulate pulsatile drug delivery system for treating nocturnal asthma , 2010, Drug delivery.

[7]  Wei He,et al.  Study on colon-specific pectin/ethylcellulose film-coated 5-fluorouracil pellets in rats. , 2008, International journal of pharmaceutics.

[8]  M. Rabišková,et al.  Differences in Characteristics of Pellets Prepared by Different Pelletization Methods , 2008 .

[9]  Shishu,et al.  Stomach-specific drug delivery of 5-fluorouracil using floating alginate beads , 2007, AAPS PharmSciTech.

[10]  K. Pathak,et al.  Osmotic flow through asymmetric membrane: A means for controlled delivery of drugs with varying solubility , 2006, AAPS PharmSciTech.

[11]  J. Nunthanid,et al.  Alginate-based pellets prepared by extrusion/spheronization: a preliminary study on the effect of additive in granulating liquid. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[12]  Sanjay K. Jain,et al.  Perspectives of biodegradable natural polysaccharides for site-specific drug delivery to the colon. , 2007, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[13]  X. Mei,et al.  In vitro release and in vivo absorption in beagle dogs of meloxicam from Eudragit FS 30 D-coated pellets. , 2006, International journal of pharmaceutics.

[14]  Da-wei Chen,et al.  [Drug release mechanism of famotidine time-controlled release pellets]. , 2006, Yao xue xue bao = Acta pharmaceutica Sinica.

[15]  Y. Kawashima,et al.  pH-sensitive microparticles for oral drug delivery , 2006 .

[16]  S. Chandran,et al.  Multiparticulate formulation approach to colon specific drug delivery: current perspectives. , 2006, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[17]  F. Sadeghi,et al.  Statistical optimization of indomethacin pellets coated with pH-dependent methacrylic polymers for possible colonic drug delivery. , 2005, International journal of pharmaceutics.

[18]  V. Sinha,et al.  Polysaccharide Matrices for Microbially Triggered Drug Delivery to the Colon , 2004, Drug development and industrial pharmacy.

[19]  J. Chaumeil,et al.  Production of Carbopol® 974P and Carbopol® 971P Pellets by Extrusion‐Spheronization: Optimization of the Processing Parameters and Water Content , 2004, Drug development and industrial pharmacy.

[20]  A. Fujimura,et al.  A comparative pharmacology study between the intracolonic and oral routes of 5-FU administration in a colon cancer-bearing Yoshida sarcoma rat model. , 2004, Journal of pharmacological sciences.

[21]  Charles E. Martin,et al.  Pharmaceutical Extrusion Technology , 2003 .

[22]  C. Rhodes,et al.  Coatings for controlled-release drug delivery systems. , 1998, Drug development and industrial pharmacy.

[23]  K. Amighi,et al.  Influence of curing conditions on the drug release rate from EudragitNESOD film coated sustained-release theophylline pellets , 1997 .

[24]  P. Watts,et al.  Colonic Drug Delivery , 1997 .

[25]  A. Munakata,et al.  Improved localizing method of radiopill in measurement of entire gastrointestinal pH profiles: colonic luminal pH in normal subjects and patients with Crohn's disease. , 1997, The American journal of gastroenterology.

[26]  K. Knop Influence of buffer solution composition on drug release from pellets coated with neutral and quaternary acrylic polymers and on swelling of free polymer films , 1996 .

[27]  Jean Paul Remon,et al.  Extrusion-spheronisation A literature review , 1995 .

[28]  A. Gazzaniga,et al.  Oral delayed-release system for colonic specific delivery☆ , 1994 .

[29]  S. Goskonda,et al.  Response surface optimization of high dose pellets by extrusion and spheronization , 1993 .

[30]  A. Rubinstein Microbially controlled drug delivery to the colon , 1990, Biopharmaceutics & drug disposition.

[31]  S. S. Davis,et al.  The in‐vivo evaluation of an osmotic device (Osmet) using gamma scintigraphy , 1984, The Journal of pharmacy and pharmacology.

[32]  C. Heidelberger,et al.  In vivo kinetics of thymidylate synthetase inhibition of 5-fluorouracil-sensitive and -resistant murine colon adenocarcinomas. , 1982, Cancer research.

[33]  O. Drummer,et al.  Fluorouracil Therapy in Patients with Carcinoma of the Large Bowel: A Pharmacokinetic Comparison of Various Rates and Routes of Administration , 1978, Clinical pharmacokinetics.

[34]  K. A. Khan The concept of dissolution efficiency , 1975, The Journal of pharmacy and pharmacology.